Delivery Order SPE2DB20D2104-SPE2DB24FR83H
- Not listed
- This federal contract award is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $90,003.59, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the...
- This federal contract award, valued at $1,335.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the pharmaceutical product VASCEPA 1 GM CAPSULE 120S, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
- This federal contract award is for the delivery of Vascepa 1 GM capsules to the Defense Logistics Agency (DLA) for a total ceiling value of $13,399.15. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 31, 2023, with a completion date of February 1, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
- This federal contract award, valued at $2,031.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VASCEPA 1 GM CAPSULE 120S. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc. This IDC with the DLA Troop Support Medical serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VASCEPA 1 GM CAPSULE 120S. The $1,519.81 firm fixed-price delivery order was awarded on December 3, 2021, with a completion date of December 6, 2021. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is for the delivery of Vascepa 1 GM capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,066.50 and was awarded on September 7, 2022, with a completion date of September 8, 2022. It is a Firm Fixed Price Delivery Order contract. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,933.49 firm fixed price delivery order is for the supply of VASCEPA 1 GM capsules. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,318.76 firm fixed-price delivery order is for the supply of Vascepa 1 GM capsules. The contract has an ultimate completion date of October 18, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of...
- This federal contract award, valued at $1,431.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product. This appears to be a firm-fixed-price delivery order contract with a completion date of May 12, 2023. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a...
- This federal contract award to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product. The $1,919.46 Firm Fixed Price delivery order has an ultimate completion date of October 23, 2023. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical products to various government agencies, particularly supporting military and veterans'...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR83HDelivery Order
This federal contract award is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company that serves as a key supplier to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract has a ceiling value of $3,423.52 and is a Delivery Order with a Firm Fixed Price pricing type. The contract has no set-aside designation, indicating it was awarded through full and open competition. The contract has an ultimate completion date of December 29, 2023 and was awarded on December 28, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 12/28/23 |